Access to a supportive community of people on similar journeys provides encouragement, shared experiences, and the reminder that youre not doing this alone
With roughly 1 in 8 American adults now taking a GLP-1, millions of people could be caught between giving up a potentially life-altering medication and accepting a daily toll on their quality of life, often without the specialized care that is proven to help
With Nurx, getting professional support is easier than ever
Chapman M
Tirzepatide is glucose-dependent in its mechanism, meaning it stimulates insulin secretion only when blood glucose is elevated
Alnylam and Inceptive have reached a strategic AI collaboration to accelerate the development of RNAi therapy On June 3, 2026, Alnylam Pharmaceuticals (NASDAQ: ALNY) and lnceptive Nucleics, a company dedicated to building life science foundation models, announced today that they have signed a strategic partnership agreement aimed at accelerating the development of innovative therapeutic drugs